Ocular Therapeutix (OCUL) COO Donald Notman Sells 1,099 Shares

What Happened
Donald Notman, Chief Operating Officer of Ocular Therapeutix (OCUL), sold 1,099 shares in an open-market transaction on August 31, 2026. The weighted-average price reported was $10.24, for a total proceeds of approximately $11,254. The sale was a non-discretionary, automatic "sell-to-cover" to satisfy tax withholding tied to restricted stock units that vested on August 29, 2026.

Key Details

• Transaction date: 2026-08-31; Form 4 filed: 2026-09-02 (timely filing).
• Reported price: weighted average $10.24; individual sale prices ranged $10.16–$10.38.
• Shares sold: 1,099; proceeds ≈ $11,254.
• Reason/footnote: Sale made under a durable automatic sale instruction (sell-to-cover) adopted May 13, 2022; not a discretionary trade. (Footnote F1)
• Additional note: Footnote F3 indicates the reporting person includes 1,272 shares acquired under the ESPP on June 30, 2026.
• Shares owned after the transaction: not specified in the provided excerpt of the filing.

Context
This was a routine tax-withholding sale tied to RSU vesting, not an opportunistic or discretionary sale by the insider. Such sell-to-cover transactions are common and typically reflect tax obligations rather than a directional view on the stock.